Literature DB >> 19749406

The neuropathology of older persons with and without dementia from community versus clinic cohorts.

Julie A Schneider1, Neelum T Aggarwal, Lisa Barnes, Patricia Boyle, David A Bennett.   

Abstract

Community-based cohorts of older persons may differ neuropathologically from clinic-based cohorts. This study investigated age-related pathologies in persons with and without dementia and included autopsied participants from two community-based cohorts, the Rush Religious Orders Study (n=386) and the Memory and Aging Project (n=195), and one clinic-based cohort, the Clinical Core of the Rush Alzheimer's Disease Center (n=392). Final clinical diagnoses included no cognitive impairment (n=202), mild cognitive impairment (MCI) (n=150), probable Alzheimer's disease (AD) (n=474), possible AD (n=88), and other dementias (n=59). Postmortem diagnoses included pathologic AD, cerebral infarcts, and Lewy body disease. Community-based persons with clinical AD had less severe AD pathology (p<0.001) and had more cerebral infarcts (p<0.001) compared to clinic-based persons. Additionally, community-based persons with MCI had more infarcts compared to clinic-based persons. Overall, there was a higher proportion of Lewy bodies and atypical pathologies in the clinic-based compared to the community-based cohorts (p<0.001). Community-based persons with probable AD show less severe AD pathology and more often have infarcts and mixed pathologies; those with MCI more often have infarcts and mixed pathologies. Overall, clinic-based persons have more Lewy bodies and atypical pathologies. The spectrum of pathologies underlying cognitive impairment in clinic-based cohorts differs from community-based cohorts.

Entities:  

Mesh:

Year:  2009        PMID: 19749406      PMCID: PMC2853869          DOI: 10.3233/JAD-2009-1227

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  36 in total

1.  Rate of cognitive decline and mortality in Alzheimer's disease.

Authors:  J S Hui; R S Wilson; D A Bennett; J L Bienias; D W Gilley; D A Evans
Journal:  Neurology       Date:  2003-11-25       Impact factor: 9.910

2.  Age-associated prevalence and risk factors of Lewy body pathology in a general population: the Hisayama study.

Authors:  Yoshinobu Wakisaka; Akiko Furuta; Yumihiro Tanizaki; Yutaka Kiyohara; Mitsuo Iida; Toru Iwaki
Journal:  Acta Neuropathol       Date:  2003-08-02       Impact factor: 17.088

3.  A clinicopathological comparison of community-based and clinic-based cohorts of patients with dementia.

Authors:  F Massoud; G Devi; Y Stern; A Lawton; J E Goldman; Y Liu; S S Chin; R Mayeux
Journal:  Arch Neurol       Date:  1999-11

4.  Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS).

Authors: 
Journal:  Lancet       Date:  2001-01-20       Impact factor: 79.321

5.  Participation in cognitively stimulating activities and risk of incident Alzheimer disease.

Authors:  Robert S Wilson; Carlos F Mendes De Leon; Lisa L Barnes; Julie A Schneider; Julia L Bienias; Denis A Evans; David A Bennett
Journal:  JAMA       Date:  2002-02-13       Impact factor: 56.272

6.  Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  D S Knopman; S T DeKosky; J L Cummings; H Chui; J Corey-Bloom; N Relkin; G W Small; B Miller; J C Stevens
Journal:  Neurology       Date:  2001-05-08       Impact factor: 9.910

7.  Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology.

Authors:  J A Schneider; R S Wilson; J L Bienias; D A Evans; D A Bennett
Journal:  Neurology       Date:  2004-04-13       Impact factor: 9.910

8.  Natural history of mild cognitive impairment in older persons.

Authors:  D A Bennett; R S Wilson; J A Schneider; D A Evans; L A Beckett; N T Aggarwal; L L Barnes; J H Fox; J Bach
Journal:  Neurology       Date:  2002-07-23       Impact factor: 9.910

9.  Impact of referral bias on clinical and epidemiological studies of Alzheimer's disease.

Authors:  E Kokmen; Y Ozsarfati; C M Beard; P C O'Brien; W A Rocca
Journal:  J Clin Epidemiol       Date:  1996-01       Impact factor: 6.437

10.  Individual differences in rates of change in cognitive abilities of older persons.

Authors:  Robert S Wilson; Laurel A Beckett; Lisa L Barnes; Julie A Schneider; Julie Bach; Denis A Evans; David A Bennett
Journal:  Psychol Aging       Date:  2002-06
View more
  152 in total

1.  Microinfarcts, brain atrophy, and cognitive function: the Honolulu Asia Aging Study Autopsy Study.

Authors:  Lenore J Launer; Timothy M Hughes; Lon R White
Journal:  Ann Neurol       Date:  2011-11       Impact factor: 10.422

Review 2.  CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD.

Authors:  Alessandro Stefani; Livia Brusa; Enrica Olivola; Mariangela Pierantozzi; Alessandro Martorana
Journal:  J Neural Transm (Vienna)       Date:  2012-05-24       Impact factor: 3.575

Review 3.  Suspected non-Alzheimer disease pathophysiology--concept and controversy.

Authors:  Clifford R Jack; David S Knopman; Gaël Chételat; Dennis Dickson; Anne M Fagan; Giovanni B Frisoni; William Jagust; Elizabeth C Mormino; Ronald C Petersen; Reisa A Sperling; Wiesje M van der Flier; Victor L Villemagne; Pieter J Visser; Stephanie J B Vos
Journal:  Nat Rev Neurol       Date:  2016-01-18       Impact factor: 42.937

4.  Braak staging, plaque pathology, and APOE status in elderly persons without cognitive impairment.

Authors:  Elliott J Mufson; Michael Malek-Ahmadi; Sylvia E Perez; Kewei Chen
Journal:  Neurobiol Aging       Date:  2015-10-20       Impact factor: 4.673

5.  Dissociating Statistically-Determined Alzheimer's Disease/Vascular Dementia Neuropsychological Syndromes Using White and Gray Neuroradiological Parameters.

Authors:  Catherine C Price; Jared J Tanner; Ilona M Schmalfuss; Babette Brumback; Kenneth M Heilman; David J Libon
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

6.  Association Between Vascular Pathology and Rate of Cognitive Decline Independent of Alzheimer's Disease Pathology.

Authors:  Ali Ezzati; Cuiling Wang; Richard B Lipton; Dorothea Altschul; Mindy J Katz; Dennis W Dickson; Carol A Derby
Journal:  J Am Geriatr Soc       Date:  2017-04-13       Impact factor: 5.562

Review 7.  Challenges of multimorbidity of the aging brain: a critical update.

Authors:  Kurt A Jellinger; Johannes Attems
Journal:  J Neural Transm (Vienna)       Date:  2014-08-05       Impact factor: 3.575

8.  TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia.

Authors:  Bryan D James; Robert S Wilson; Patricia A Boyle; John Q Trojanowski; David A Bennett; Julie A Schneider
Journal:  Brain       Date:  2016-11-01       Impact factor: 13.501

9.  Vascular risk factors are associated with longitudinal changes in cerebrospinal fluid tau markers and cognition in preclinical Alzheimer's disease.

Authors:  Isabelle Bos; Stephanie J B Vos; Suzanne E Schindler; Jason Hassenstab; Chengjie Xiong; Elizabeth Grant; Frans Verhey; John C Morris; Pieter Jelle Visser; Anne M Fagan
Journal:  Alzheimers Dement       Date:  2019-08-01       Impact factor: 21.566

10.  An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer's disease.

Authors:  Lidia Sarro; Nirubol Tosakulwong; Christopher G Schwarz; Jonathan Graff-Radford; Scott A Przybelski; Timothy G Lesnick; Samantha M Zuk; Robert I Reid; Mekala R Raman; Bradley F Boeve; Tanis J Ferman; David S Knopman; Giancarlo Comi; Massimo Filippi; Melissa E Murray; Joseph E Parisi; Dennis W Dickson; Ronald C Petersen; Clifford R Jack; Kejal Kantarci
Journal:  Alzheimers Dement       Date:  2016-08-10       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.